BridgeMD
New treatment option for Mental Fatigue
Official title tAN for First Responders
ClinicalTrials.gov ID: NCT07109349
What this study is testing
- What it's testing
- This study is designed as an open label, single arm, decentralized clinical study in which first responders will receive transcutaneous auricular neurostimulation (tAN), which targets the auricular branch of the vagus nerve (ABVN) via the mastoid and the auriculotemporal nerve (ATN) anterior to the tragus. Participants will be enrolled in the study over the course of eight weeks (56 days).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant is currently employed in a first responder position
- Age ≥ 18 years
- Reliable access to an internet-enabled device to complete required questionnaires
- GAD-7 score ≥ 5
You likely can't join if
- Participant has a history of epileptic seizures
- Participant has a history of neurologic diseases or traumatic brain injury
- Participant has presence of devices (e.g., pacemakers, cochlear prostheses or implants, neurostimulators)
- Participant has abnormal left ear anatomy or ear infection present
- Participant has auditory impairment of the left ear (ruptured eardrum, deafness, tinnitus, etc.)
- Participant is currently enrolled in another treatment trial
See the full eligibility criteria
- Participant is currently employed in a first responder position
- Age ≥ 18 years
- Reliable access to an internet-enabled device to complete required questionnaires
- GAD-7 score ≥ 5
- Participant has a history of epileptic seizures
- Participant has a history of neurologic diseases or traumatic brain injury
- Participant has presence of devices (e.g., pacemakers, cochlear prostheses or implants, neurostimulators)
- Participant has abnormal left ear anatomy or ear infection present
- Participant has auditory impairment of the left ear (ruptured eardrum, deafness, tinnitus, etc.)
- Participant is currently enrolled in another treatment trial
- Women of childbearing potential, not using adequate contraception as per the investigator's judgement
- Females who are pregnant or lactating
- Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or may influence the result of the...
The study team makes the final eligibility decision.
Where it's taking place
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dallas, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.